Safety and efficacy of jaktinib in the treatment of Janus kinase inhibitor‐naïve patients with myelofibrosis: Results of a phase II trial

Author:

Zhang Yi1234ORCID,Zhou Hu5,Jiang Zhongxing6,Wu Dengshu7,Zhuang Junling8ORCID,Li Wei9,Jiang Qian10ORCID,Wang Xiuli11,Huang Jinwen12,Zhu Huanling13ORCID,Yang Linhua14,Du Xin15,Li Fei16,Xia Ruixiang17,Zhang Feng18,Hu Jianda19ORCID,Li Yan20,Hu Yu21ORCID,Liu Jing22,Jin Chenghao23,Sun Kai24,Zhou Zeping25,Wu Liqing26,Yu Wenjuan1234,Jin Jie1234ORCID

Affiliation:

1. Department of Hematology The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou P.R. China

2. Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy Zhejiang University Hangzhou P.R. China

3. Zhejiang Provincial Clinical Research Center for Hematological Disorders Hangzhou P.R. China

4. Zhejiang University Cancer Center Hangzhou P.R. China

5. Department of Hematology The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital Zhengzhou P.R. China

6. Department of Hematology The First Affiliated Hospital of Zhengzhou University Zhengzhou P.R. China

7. Department of Hematology Xiangya Hospital, Central South University Changsha P.R. China

8. Department of Hematology Peking Union Medical College Hospital (Dongdan Campus) Beijing P.R. China

9. Department of Hematology, Cancer Center The First Hospital of Jilin University Changchun P.R. China

10. Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease Beijing Key Laboratory of Hematopoietic Stem Cell Beijing P.R. China

11. Department of Oncology Hematology The Second Hospital of Jilin University Changchun P.R. China

12. Department of Hematology Sir Run Run Shaw Hospital, Zhejiang University School of Medicine Hangzhou P.R. China

13. Department of Hematology West China Hospital, Sichuan University Chengdu P.R. China

14. Department of Hematology The Second Hospital of Shanxi Medical University Taiyuan P.R. China

15. Department of Hematology Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences Guangzhou P.R. China

16. Department of Hematology The First Affiliated Hospital of Nanchang University Nanchang P.R. China

17. Department of Hematology The First Affiliated Hospital of Anhui Medical University Hefei P.R. China

18. Department of Hematology The First Affiliated Hospital of Bengbu Medical College Bengbu P.R. China

19. Fujian Institute of Hematology Fujian Medical University Union Hospital Fuzhou P.R. China

20. Department of Hematopathology The First Hospital of China Medical University Shenyang P.R. China

21. Department of Hematology, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan P.R. China

22. Department of Hematology Third Xiangya Hospital of Central South University Changsha P.R. China

23. Department of Hematology Jiangxi Provincial People's Hospital Nanchang P.R. China

24. Department of Hematology Henan Provincial People's Hospital Zhengzhou P.R. China

25. Department of Hematology The Second Affiliated Hospital of Kunming Medical University Kunming P.R. China

26. Suzhou Zelgen Biopharmaceuticals Co, Ltd Suzhou P.R. China

Publisher

Wiley

Subject

Hematology

Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3